Association between ROX index and outcomes of High flow nasal cannula in post-extubated patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20211020004

Enrollment

236

Registered

2021-10-20

Start date

2018-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The limitation of our study are 1) retrospective chart review study, 2) the study limit just participants in internal medicine department ROX index, HFNC, Post-extubation

Interventions

Patients who success use of HFNC after extubation regardless of time,Patients who failure use of HFNC after extubation within 2-24 hours

Other,Other

Success HFNC ,Failure HFNC

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All of the following : 1.Age more than 18 years old 2.Respiratory failure requiring intubation and mechanical ventilation 3. Requiring high flow nasal cannula after extubation

Exclusion criteria

Exclusion criteria: 1.Unretrievable data from medical records 2.Use of other types of oxygen therapy before High flow nasal cannula during post-extubation period

Design outcomes

Primary

Measure	Time frame
ROX index within 24 hours after HFNC uses Cutoffs for the ROX	—

Secondary

Measure	Time frame
Duration of HFNC use within 24 hours after HFNC use hours ,Hospital length of stay within 3 months after admission days,ICU length of stay within 3 months after ICU admission days,28 day mortality with in 28 day after admission Percent ,Hospital mortality within 3 months after admission Percent	—

Countries

Thailand

Contacts

Public ContactMetanee Songrin

Faculty of Medicine,Thammasat University Hospital

drmetanee@gmail.com0839703746

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026